FDA Compounding Definition Brings States Into Oversight Fold
This article was originally published in The Pink Sheet Daily
Executive Summary
State regulators seem to agree with FDA about confusion over regulatory responsibility, saying writing consistent definitions for compounding and manufacturing will help determine future FDA involvement.
You may also be interested in...
FDA Compounder Inspections: States Taking Early Leave
State inspectors did not accompany FDA for the full duration of facility inspections and now the agency is turning over the findings to them.
Compounding: FDA Refining Post-Inspection Hand-off To States
When the agency finds a traditional compounder during an inspection, it asks state boards of pharmacy to ensure corrections are made.
Compounding Warning Letter Format Unchanged Since Legislation
FDA’s first two warning letters since draft compounding guidances may be another way to encourage outsourcer registration.